Deutsche Bank’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Deutsche Bank’s Portfolio SVNT Stock Details SVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-50,001	Closed	-$31K	–	6091
2013 Q3	$31K	Buy	50,001 +1	+0%	+$1	﹤0.01%	4814
2013 Q2	$28K	Buy	+50,000	New	+$34.8K	﹤0.01%	4694

Other funds holding SVNT

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

PSC

Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Deutsche Bank's SVNT Position: Q4 2013 in Review

Deutsche Bank sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 50,001 shares — an estimated $31K sold.

Deutsche Bank first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $31K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

Deutsche Bank reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
Deutsche Bank sold 50,001 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $31K.
Deutsche Bank first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
Deutsche Bank's SAVIENT PHARMACEUTICALS INC position peaked at $31K in Q3 2013.
7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Deutsche Bank's 13F filing for Q4 2013, filed 18 Feb 2014.